Skip to content
Menu

Clover Health Investments, Corp. CLOV

Full chart Compare
Set alert

Price alert · CLOV

All alert types
3.73 USD -0.04 (-1.06%)

Regular-session close

3.75 +0.02 +0.57%

After hours · Nov 20, 7:55 PM ET

3.68 Day range 3.96
1.58 52-week range 5.59
YTD
+58.72%
1 year
+72.69%

5D -1.30 (-25.84%)

44.505MonTueWedThuFri3.73
Market cap
2.00B
Revenue (ttm)
2.74B
Profit margin
0.45%
EPS (ttm)
0.01
Shares out
439.71M
P/E ratio
373.00
Forward P/E
20.72
YTD return
+58.72%
1-year return
+72.69%
Volume
7.25M
Avg volume
4.42M
Open
3.77
Previous close
3.77
Day's range
3.68 – 3.96
52-week range
1.58 – 5.59
Beta
2.48
Price target
5.60 (+50.1%)
Earnings date
Feb 25, 2027

Key statistics

50-day average
4.61
200-day average
3.70
Enterprise value
1.69B
Price / sales
0.73
Price / book
5.09
Revenue growth
53.10%
Free cash flow
87.48M
Total cash
332.74M
Return on equity
3.40%
Short % of float
5.43%

Fundamental scorecard

13 of 25 checks passed on CLOV’s reported financials

ValueGrowthProfitabilityHealthDividend

13of 25 checks passed

  • Value 1 of 5
  • Growth 4 of 5
  • Profitability 3 of 5
  • Financial health 5 of 5
  • Dividend 0 of 5

Statements to Sep 30, 2026.

Financials — quick view

All financials
CLOV Revenue — quarterly 759.30M
CLOV Net income — quarterly 6.43M
CLOV EPS — quarterly 0.01

Earnings

CLOV recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Feb 25, 2027Dec 30, 2026-0.05———
Nov 4, 2026Sep 30, 2026-0.005070.01+0.02+297.24%
Aug 5, 2026Jun 30, 20260.038640.05+0.01+29.40%
May 6, 2026Mar 31, 20260.070.070.000.00%
Feb 26, 2026Dec 31, 2025-0.10212-0.05+0.05+51.04%
Nov 4, 2025Sep 30, 20250.02-0.05-0.07-350.00%

Upgrades / downgrades

CLOV analyst upgrades and downgrades
DateFirmActionFromTo
Nov 5, 2026UBSmainNeutralNeutral
Oct 28, 2026Needhaminit—Buy
Aug 6, 2026UBSmainNeutralNeutral
Jul 21, 2026Canaccord GenuitymainBuyBuy
Jun 11, 2026UBSmainNeutralNeutral
Jun 4, 2026Canaccord GenuitymainBuyBuy

About Clover Health Investments, Corp.

Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company offers preferred provider organization and health maintenance organization plans to medicare-eligible individuals. It also operates Clover Assistant, a software platform for physicians to detect, identify, and manage chronic diseases. The company was founded in 2014 and is based in Wilmington, Delaware.

Sector
Healthcare
Industry
Healthcare Plans
Country
United States

News

Your note

Sign in to keep a note on CLOV — it syncs with the Stock Master app.

Insider holders

CLOV insider holders
InsiderRelationLatest transactionDateShares held
CLINTON CHELSEADirectorStock Award(Grant)Jan 5, 2025602,814
GARIPALLI VIVEKDirector and Beneficial Owner of more than 10% of a Class of SecurityConversion of Exercise of derivative securityJan 6, 20261,856,250
KOUZOUKAS DEMETRIOS LDirectorStock Award(Grant)Jan 5, 2026605,980
KUIPERS PETER JChief Financial OfficerStock Award(Grant)May 18, 20256,349,970
PRIEST BRADY PATRICKOfficerSaleMay 12, 20262,040,220
REYNOSO JAMIE L.OfficerSaleOct 18, 20262,770,350

Institution ownership

CLOV institution ownership
Holder% heldSharesValueReported
Blackrock Inc.8.30%36,508,668136.18MSep 29, 2026
Vanguard Capital Management LLC4.18%18,381,77068.56MSep 29, 2026
Geode Capital Management, LLC2.53%11,115,99041.46MSep 29, 2026
State Street Corporation2.43%10,693,70539.89MSep 29, 2026
Nuveen, LLC1.78%7,818,02329.16MSep 29, 2026
Vanguard Portfolio Management LLC1.73%7,590,92728.31MSep 29, 2026

Fund ownership

CLOV fund ownership
Holder% heldSharesValueReported
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund2.95%12,979,04948.41MJun 29, 2026
iShares Trust-iShares Russell 2000 ETF2.48%10,923,26040.74MSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund1.06%4,646,55217.33MJun 29, 2026
Fidelity Salem Street Trust-Fidelity Small Cap Index Fund1.05%4,607,35017.19MAug 30, 2026
iShares Trust-iShares Russell 2000 Growth ETF0.89%3,928,21114.65MSep 29, 2026
VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund0.55%2,411,2158.99MAug 30, 2026